Randomized studies comparing standard sepsis management with standard management plus early mobilization, high-protein nutritional interventions, or novel anabolic pharmacotherapies (e.g., selective androgen receptor modulators) in sarcopenic patients will help determine causality rather than mere association. The gene discussed is AR; the disease is Sepsis.